Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Praxis Precision Medicines Inc (NASDAQ: PRAX) was $54.22 for the day, down -4.19% from the previous closing price of $56.59. In other words, the price has decreased by -$4.19 from its previous closing price. On the day, 0.56 million shares were traded. PRAX stock price reached its highest trading level at $56.59 during the session, while it also had its lowest trading level at $53.71.
Ratios:
Our analysis of PRAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.44 and its Current Ratio is at 8.44. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 07, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $80.
H.C. Wainwright reiterated its Buy rating for the stock on March 03, 2025, while the target price for the stock was revised from $120 to $105.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 14 ’24 when Nemiroff Alex sold 8,239 shares for $80.20 per share. The transaction valued at 660,827 led to the insider holds 10,301 shares of the business.
Mastrocola Lauren sold 5,188 shares of PRAX for $424,318 on Nov 14 ’24. The Principal Accounting Officer now owns 5,613 shares after completing the transaction at $81.78 per share. On Nov 14 ’24, another insider, Mastrocola Lauren, who serves as the Officer of the company, bought 5,189 shares for $81.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 1104407168 and an Enterprise Value of 777481216. For the stock, the TTM Price-to-Sale (P/S) ratio is 136.01 while its Price-to-Book (P/B) ratio in mrq is 2.51. Its current Enterprise Value per Revenue stands at 95.725 whereas that against EBITDA is -3.341.
Stock Price History:
The Beta on a monthly basis for PRAX is 2.65, which has changed by -0.045086324 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, PRAX has reached a high of $91.83, while it has fallen to a 52-week low of $26.70. The 50-Day Moving Average of the stock is 16.66%, while the 200-Day Moving Average is calculated to be -4.82%.
Shares Statistics:
PRAX traded an average of 353.81K shares per day over the past three months and 491410 shares per day over the past ten days. A total of 20.34M shares are outstanding, with a floating share count of 18.22M. Insiders hold about 10.57% of the company’s shares, while institutions hold 113.37% stake in the company. Shares short for PRAX as of 1752537600 were 1941375 with a Short Ratio of 5.49, compared to 1749772800 on 1742912. Therefore, it implies a Short% of Shares Outstanding of 1941375 and a Short% of Float of 9.55.
